Device type · QAN
Stent, Iliac Vein
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QAN
Cardiovascular
Device class
Class III
FDA decisions since 2015
6
510(k), De Novo and PMA
Adverse event reports
166
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Stent, Iliac Vein
- Product code
- QAN
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for QAN
Latest FDA decisions
Philips Image Guided Therapy Corporation
P230021 · Decided Dec 26, 2023 · 176 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
P200026 · Decided Oct 21, 2020 · 177 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
P200023 · Decided Oct 9, 2020 · 179 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
3 more FDA decisions with a free account
Reports received
166
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
63
38% of reports
Injury reports
99
60% of reports
Death reports
4
2.4% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 7 | 2 | 0 | 0 |
| Jan 24 | 3 | 1 | 0 | 0 |
| Feb 24 | 5 | 1 | 0 | 0 |
| Mar 24 | 7 | 4 | 0 | 0 |
| Apr 24 | 3 | 10 | 0 | 0 |
| May 24 | 5 | 4 | 0 | 0 |
| Jun 24 | 7 | 2 | 0 | 0 |
| Jul 24 | 8 | 6 | 0 | 0 |
| Aug 24 | 7 | 9 | 0 | 0 |
| Sep 24 | 2 | 9 | 0 | 0 |
| Oct 24 | 6 | 4 | 0 | 0 |
| Nov 24 | 6 | 3 | 0 | 0 |
| Dec 24 | 7 | 9 | 0 | 0 |
| Jan 25 | 8 | 4 | 0 | 0 |
| Feb 25 | 3 | 7 | 0 | 0 |
| Mar 25 | 7 | 2 | 0 | 0 |
| Apr 25 | 4 | 16 | 1 | 0 |
| May 25 | 5 | 6 | 0 | 0 |
| Jun 25 | 3 | 7 | 0 | 0 |
| Jul 25 | 5 | 6 | 0 | 0 |
| Aug 25 | 15 | 10 | 0 | 0 |
| Sep 25 | 6 | 16 | 0 | 0 |
| Oct 25 | 6 | 14 | 0 | 0 |
| Nov 25 | 6 | 7 | 0 | 0 |
| Dec 25 | 3 | 10 | 0 | 0 |
| Jan 26 | 7 | 14 | 0 | 0 |
| Feb 26 | 1 | 8 | 0 | 0 |
| Mar 26 | 5 | 11 | 0 | 0 |
| Apr 26 | 4 | 7 | 1 | 0 |
| May 26 | 7 | 1 | 2 | 0 |
| Jun 26 | 4 | 8 | 0 | 0 |
| Jul 26 | 8 | 7 | 0 | 0 |
| Aug 26 | 7 | 14 | 1 | 0 |
| Sep 26 | 7 | 6 | 0 | 0 |
| Oct 26 | 4 | 6 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
3 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem56
- Material Deformation26
- Obstruction of Flow21
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions72
- Obstruction/Occlusion24
- Restenosis20
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1098-2026 · Started Dec 4, 2025 · Posted by FDA Jan 15, 2026
Reason given: Stents may be impacted by a Nitinol anomaly which causes a reduced stent diameter when deployed and corresponding reduced radial force. Issue may result in stent migration.
Cause as FDA categorized it: Under Investigation by firm
- Abre Venous Self-expanding Stent System, Product Numbers: a) AB9U14080090; b) AB9U18100090; c) AB9G14100090Open, Classified
Z-1317-2024 · Started Feb 16, 2024 · Posted by FDA Mar 19, 2024
Reason given: There is a potential for sterile package breach.
Cause as FDA categorized it: Process control
- Instructions for Use for all model numbers of the Medtronic Abre Venous Self-Expanding Stent System.Terminated
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Z-0464-2022 · Started Nov 19, 2021
Reason given: There have been reports of stent migration.
Cause as FDA categorized it: Other
6 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.